StockTipsArenaBeta

BUY Divi's Laboratories Limited — Rajesh Palviya, Axis Securities

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))13 Jul 2026via ET Now

Entry₹6,960Inferred
Target₹7,150
Total upside +2.73% (call closed)
Stop loss₹6,875-1.22% risk
Exit₹7,15014 Jul 2026, 1:00 pm
Target hit+2.73%0.00%upside left
Follow Rajesh Palviya for new calls(27% target hit, 179 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 1 active Swing call on DIVISLABSee 150 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 14 Jul 2026
3 supporting0 opposing
Supports the BUY call (3)

Divi's Laboratories Recommends ₹30 Final Dividend for FY26

NewsGoogle News·13 Jul · today

(opens in new tab)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·14 Jul · today

3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·14 Jul · today

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Rajesh Palviya, Axis Securities

Every call and its outcome